Skip to content
Screener

Axogen AXGN Other Income (Expense)

Other Income (Expense) at other companies

Baxter International logo
Baxter InternationalBAX
-$6M-300%
Stryker logo
StrykerSYK
-$95M+2.1%
IAR
Integra LifeSciencesIART
$4.19M+315%
LeMaitre Vascular logo
LeMaitre VascularLMAT
-$294K-219%
Artivion logo
ArtivionAORT
$3.55M-28.5%
Bioventus logo
BioventusBVS
-$3.82M+52.6%

Other financials

Income statement

See full
Revenue$69.7M+23.1%
Gross profit$50.7M+20.6%
Operating income-$2.2M-229%
Net income-$1.5M-362%
EPS (diluted)-$0.03-400%

Balance sheet

See full
Cash & equivalents$96.6M+271%
Total debt$20.1M-70.6%
Total equity$256.3M+128%
Total assets$304.9M+48.4%

Cash flow

See full
Operating cash flow$7.2M
CapEx$893.0K+23.7%
Free cash flow$6.3M

Valuation

See full
Market cap$2.38B+277%
Enterprise value$2.31B+242%
P/S9.5×+6.4×

Profitability

See full
Gross margin74.6%+0.3pp
Operating margin-5.1%
Net margin-13.4%-17.4pp
FCF margin-12.9%-3.8pp

Returns & leverage

See full
Return on equity-18.2%-28.9pp
Debt / equity0.1×-0.5×
Current ratio6.6×+2.5×

Where this comes from

Reported directly by Axogen in its filing.

Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.

The source filing: Axogen’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 4:13 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000805928-26-000094
Line itemThree Months Ended / June 30, 2026Three Months Ended / June 30, 2025Six Months Ended / June 30, 2026Six Months Ended / June 30, 2025
Loss on extinguishment of debt(16,849)
Change in fair value of debt derivative liabilities480322
Other (expense) income, net(145)179(122)142
Total other income (expense), net640(1,093)(16,112)(3,266)
Net (loss) income$(1,516)$579$(21,100)$(3,255)
Weighted average common shares outstanding - basic53,339,25846,063,09252,562,97645,605,419
Weighted average common shares outstanding - diluted53,339,25847,980,83052,562,97645,605,419
Net (loss) income per common share - basic$(0.03)$0.01$(0.40)$(0.07)

ITEM 1 — FINANCIAL STATEMENTS

FAQ

What is Axogen's other income (expense)?
Axogen (AXGN) reported other income (expense) of $640K in Q2 2026.
How has Axogen's other income (expense) changed year-over-year?
Axogen's other income (expense) increased by 158.6% year-over-year, from -$1.09M to $640K.
What is the long-term trend for Axogen's other income (expense)?
Over 4 years (2021 to 2025), Axogen's other income (expense) has grown at a 48.0% compound annual growth rate (CAGR), from -$1.64M to -$7.85M.
What does other income (expense) mean?
Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.

Ask your AI about Axogen's other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude